Conditions: Plaque Psoriasis
Keywords: 122-0551 steroid HPA
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 25
Healthy volunteers: no

Brief summary:
Adrenal suppression effects of corticosteroids are among the most important safety concerns for this group of products. This study is designed to determine the adrenal effects of the investigational formulation of 122-0551 and characterize the steady state pharmacokinetics of the formulation.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: 122-0551
Intervention descriptions: intervention 1: Applied twice daily for 2 weeks

Protocol document: